| scholarly article | Q13442814 |
| P356 | DOI | 10.1182/BLOOD.V97.2.496 |
| P698 | PubMed publication ID | 11154228 |
| P2093 | author name string | Stein H | |
| Hummel M | |||
| Falini B | |||
| Laumen H | |||
| Wirth T | |||
| Foss HD | |||
| Demel G | |||
| Anagnostopoulos I | |||
| Marafioti T | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lymphocyte | Q715347 |
| P304 | page(s) | 496-501 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription | |
| P478 | volume | 97 |
| Q40401901 | A case of age-related EBV-associated B-cell lymphoproliferative disorder metachronously showing two distinct morphologic appearances, one of a polymorphic disease resembling classical Hodgkin lymphoma, and the other of a large-cell lymphoma |
| Q54987213 | Aberrant expression of NKL homeobox gene HLX in Hodgkin lymphoma. |
| Q39986630 | Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma. |
| Q35788374 | Aberrantly Expressed OTX Homeobox Genes Deregulate B-Cell Differentiation in Hodgkin Lymphoma |
| Q40689379 | An unbalanced translocation involving chromosome 14 is the probable cause for loss of potentially functional rearranged immunoglobulin heavy chain genes in the Epstein-Barr virus-positive Hodgkin's lymphoma-derived cell line L591. |
| Q58010999 | Analysis of Octamer-Binding Transcription Factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in Lymphomas |
| Q80347643 | Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma |
| Q82190987 | B-cell differentiation immunophenotypes in classical Hodgkin lymphomas |
| Q38389727 | BOB.1-positive Classical Hodgkin's Lymphoma Carries Hypermethylation of Its Promoter as Epigenetic Marker of Gene-silencing Memory |
| Q41969041 | Bob-1 is expressed in classic Hodgkin lymphoma |
| Q53263065 | Classical Hodgkin's Lymphoma Associated With Langerhans Cell Histiocytosis: Multiagent Chemotherapy Resulted in Histologic Resolution of Both the Classical Hodgkin's Lymphoma and Langerhans Cell Proliferation Components |
| Q33386690 | Classification of lymphoid neoplasms: the microscope as a tool for disease discovery |
| Q30653046 | CluGene: A Bioinformatics Framework for the Identification of Co-Localized, Co-Expressed and Co-Regulated Genes Aimed at the Investigation of Transcriptional Regulatory Networks from High-Throughput Expression Data |
| Q35788898 | Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells |
| Q38596350 | Contribution of the Epstein-Barr Virus to the Pathogenesis of Hodgkin Lymphoma |
| Q38185063 | Current status of prognostication in classical Hodgkin lymphoma |
| Q40769449 | Deregulation of immunoglobulin gene transcription in the Hodgkin-Reed Sternberg cell line L1236. |
| Q40669895 | Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines |
| Q40463591 | Downregulation of internal enhancer activity contributes to abnormally low immunoglobulin expression in the MedB-1 mediastinal B-cell lymphoma cell line. |
| Q51735191 | EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts. |
| Q36513571 | Epidemiology and pathologic features of Hodgkin lymphoma |
| Q39441384 | Epigenetic and transcriptional control of the 15-lipoxygenase-1 gene in a Hodgkin lymphoma cell line. |
| Q43440254 | Epstein-Barr virus-induced B-cell proliferation of Hodgkin's and Reed-Sternberg cell pheno- and genotype may develop in peripheral T-cell lymphomas |
| Q36338375 | Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. |
| Q41921960 | Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms |
| Q24675877 | Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomas |
| Q33696062 | Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death |
| Q35615770 | Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival |
| Q42538635 | Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation |
| Q34113805 | Expression of transcription factors Pu.1, Spi-B, Blimp-1, BSAP and oct-2 in normal human plasma cells and in multiple myeloma cells |
| Q83223363 | Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin's and non-Hodgkin's lymphomas: a comparative study using high throughput tissue microarrays |
| Q51965000 | Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology. |
| Q36513564 | Genomic alterations in Hodgkin's lymphoma |
| Q48358817 | Germline variation in the 3'-untranslated region of the POU2AF1 gene is associated with susceptibility to lymphoma. |
| Q38029564 | Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma? |
| Q35216401 | Hodgkin disease immunopathogenesis: long-standing questions, recent answers, further directions |
| Q34643277 | Hodgkin lymphoma |
| Q24681342 | Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL |
| Q33588862 | Hodgkin lymphoma: an update on its biology with new insights into classification |
| Q73154295 | Hodgkin's lymphoma |
| Q36611490 | Hodgkin's lymphoma and infection: findings from a UK case-control study |
| Q34564836 | Hodgkin's lymphoma: the pathologist's viewpoint |
| Q36591359 | IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis |
| Q34274124 | Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells |
| Q60345402 | Insights into the multistep transformation process of lymphomas: IgH-associated translocations and tumor suppressor gene mutations in clonally related composite Hodgkin's and non-Hodgkin's lymphomas |
| Q48036231 | Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples |
| Q40337542 | Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma |
| Q37738584 | Is Hodgkin lymphoma just another B-cell lymphoma? |
| Q43428745 | Large B-cell lymphoma with Hodgkin's features |
| Q53388471 | Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma. |
| Q47763298 | Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis |
| Q36085626 | Mechanisms of B-cell lymphoma pathogenesis |
| Q40864458 | Mediastinal Gray Zone Lymphoma: A Wider Category Than We Think? |
| Q57050339 | Microgravity induces autophagy via mitochondrial dysfunction in human Hodgkin's lymphoma cells |
| Q34480682 | Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma |
| Q34554743 | Molecular biology of Hodgkin's lymphoma |
| Q40671210 | Molecular cytogenetic characterization of four commonly used cell lines derived from Hodgkin lymphoma |
| Q36513575 | Molecular pathogenesis of Hodgkin lymphoma |
| Q61455094 | NKL homeobox gene NKX2-2 is aberrantly expressed in Hodgkin lymphoma |
| Q51402406 | Nodular lymphocyte-predominant hodgkin lymphoma with atypical T cells: a morphologic variant mimicking peripheral T-cell lymphoma. |
| Q28208976 | OCA-B regulation of B-cell development and function |
| Q35618780 | Part I: Hodgkin's lymphoma--molecular biology of Hodgkin and Reed-Sternberg cells |
| Q56986903 | Pathobiology of hodgkin lymphoma |
| Q33778402 | Pathobiology of hodgkin lymphoma. |
| Q35808376 | Pathobiology of primary mediastinal B-cell lymphoma |
| Q30248284 | Pediatric Hodgkin lymphoma: biomarkers, drugs, and clinical trials for translational science and medicine. |
| Q80464841 | Primary gastric Hodgkin's lymphoma expressing a B-Cell profile including Oct-2 and Bob-1 proteins |
| Q35036705 | Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins |
| Q34185759 | Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do? |
| Q34520636 | Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes |
| Q37004635 | Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed-Sternberg cell |
| Q35545810 | Relationship between Hodgkin's and Non-Hodgkin's Lymphomas |
| Q39240522 | Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma |
| Q34912276 | Subclonal evolution of a classical Hodgkin lymphoma from a germinal center B-cell-derived mantle cell lymphoma |
| Q34650591 | Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle. |
| Q36500552 | Targeting cellular FLICE-like inhibitory protein as a novel approach to the treatment of Hodgkin's lymphoma |
| Q34456199 | The FOXP1 transcription factor is expressed in the majority of follicular lymphomas but is rarely expressed in classical and lymphocyte predominant Hodgkin's lymphoma |
| Q37349652 | The biology of Hodgkin's lymphoma |
| Q38983067 | The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis. |
| Q35994955 | The role of interleukin-3 in classical Hodgkin's disease. |
| Q40770329 | The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease |
| Q37235019 | Treatment of Hodgkin lymphoma: the past, present, and future. |
| Q81067725 | [Classical Hodgkin's lymphoma: biology and grey zones] |
| Q53367286 | [Nodular lymphocyte predominance Hodgkin's disease and its differential diagnosis]. |
Search more.